Prosecution Insights
Last updated: August 18, 2026

Examiner: REGLAS, GEORGIANA C

Tech Center 1700 • Art Units: 1651 1653 1654 1657 1799

This examiner grants 38% of resolved cases

Performance Statistics

37.5%
Allow Rate
-27.5% vs TC avg
126
Total Applications
+31.1%
Interview Lift
1325
Avg Prosecution Days
Based on 72 resolved cases, 2023–2026

Rejection Statute Breakdown

6.9%
§101 Eligibility
11.8%
§102 Novelty
40.4%
§103 Obviousness
28.4%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17640262 ENZYME COMPOSITION Final Rejection DSM IP ASSETS B.V.
19432924 AN IMPROVED PROCESS OF PURIFICATION OF PROTEIN Final Rejection Kashiv BioSciences, LLC
18347733 METHOD FOR SELECTING CELLS, APPARATUS, AND APPARATUS SYSTEM Non-Final OA FUJIFILM Corporation
18729410 METHOD OF ENZYMATIC CLEANING TO REMOVE MICROORGANISMS OR BIOFILM FROM INDUSTRIAL EQUIPMENT Non-Final OA ECOLAB USA INC.
17558186 FUNCTIONAL COMPOSITE MEMBRANES FOR CHROMATOGRAPHY AND CATALYSIS Final Rejection California Institute of Technology
17058891 TARGETING ANABOLIC DRUGS FOR ACCELERATED FRACTURE REPAIR Final Rejection Purdue Research Foundation
17765960 PURIFICATION OF PROTEINS AND VIRAL INACTIVATION Final Rejection MERCK PATENT GMBH
17442776 PROBIOTIC BACTERIA CAPABLE OF ADAPTIVE RESPONSE TO POMEGRANATE EXTRACT AND METHODS OF PRODUCTION AND USE THEREOF Non-Final OA North Carolina State University
18073511 METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING VAGUS NERVE ASSOCIATED DISEASES, DISORDERS, AND CONDITIONS Final Rejection MarvelBiome, Inc.
17256813 IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS Non-Final OA Givaudan SA

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month